Epinephrine Injection USP — Class II drug recall D-106-2013
Terminated recall by Hospira Inc., reported 2013-01-09, distributed nationwide. Presence of Particulates; may contain glass particles
| Recall number | D-106-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2012-10-25 |
| Classified | 2012-12-28 |
| Reported by FDA | 2013-01-09 |
| Terminated | 2014-10-15 |
| Distributed | Nationwide (US) |
| Reason classes | foreign material, specification failure |
| NDC | 00409-7241-01 |
| Lot numbers | 100953A, 120803A |
| Expiration dates | 2013-10-01, 2013-12-01 |
Product
Epinephrine Injection USP, 1 mL, USP 1:1000 (1 mg/mL), SQ/IM, Hospira, Inc., Lake Forest, IL --- NDC 0409-7241-01
Reason for recall
Presence of Particulates; may contain glass particles
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-106-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.